Lack of effect of vitamin E on L-arginine-responsive endothelial dysfunction in patients with mild hypercholesterolaemia and coronary artery disease

Clinical Science

Volumn 94, Issue 2, 1998, Pages 129-134

  Chowienczyk, P J ^a   Kneale, B J ^b   Brett, S E ^a   Paganga, G ^c   Jenkins, B S ^b   Ritter, J M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

Author keywords

Acetylcholine; Antioxidants; Atherosclerosis; Endothelium; Nitric oxide; Tocopherols

Indexed keywords

ACETYLCHOLINE; ALPHA TOCOPHEROL; ARGININE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NITROPRUSSIDE SODIUM; TRIACYLGLYCEROL;

ADULT; AGED; ARM BLOOD FLOW; ARTICLE; BRACHIAL ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; ENDOTHELIUM; FEMALE; FOREARM; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

EID: 0031983471     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0940129     Document Type: Article

References (43)

1. Zeiher AM, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83: 391-401.
2. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992; 340: 1430-2.
3. Andrews HE, Bruckdorfer KR, Dunn RC, Jacobs M. Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature (London) 1987; 327: 237-9.
4. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study. Lancet 1994; 344: 1383-9.
5. Treasure CB, Klein JL, Weintraub WS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med 1995; 332: 481-7.
6. Jukema JW, Bruschke AVJ, van Boven AdJ, et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 1995; 91: 2528-40.
7. Stroes ESG, Koomans HA, de Bruin TWA, Rabelink TJ. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet 1995; 346: 467-71.
8. O'Driscoll G, Green D, Taylor RR. Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. Circulation 1997; 95: 1126-31.
9. Klemsdal TO, Andersson TLG, Matz J, Ferns GAA, Gjesdal K, Änggård EE. Vitamin E restores endothelium dependent vasodilatation in cholesterol fed rabbits: in vivo measurements by photoplethysmography. Cardiovasc Res 1994; 28: 1397-402.
10. Matz J, Andersson TLG, Ferns GAA, Änggård EE. Dietary vitamin E increases the resistance to lipoprotein oxidation and attenuates endothelial dysfunction in the cholesterol-fed rabbit. Atherosclerosis 1994; 110: 241-9.
11. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-6.
12. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary artery disease in women. N Engl J Med 1993; 328: 1444-9.
13. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-6.
14. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; 2: 997-1000.
15. G-monomethyl-L-arginine of vasodilator effects of acetylcholine and methacholine in human forearm vasculature. Br J Pharmacol 1993; 110: 736-8.
16. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in the coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet 1991; 338: 1546-50.
17. Chowienczyk PJ, Watts GF, Cockcroft JR, Brett SE, Ritter JM. Sex differences in endothelial function in normal and hypercholesterolaemic subjects. Lancet 1994; 344: 305-6.
18. Whitney RJ. The measurement of volume changes in human limbs. J Physiol (London) 1953; 121: 1-27.
19. Hokanson DE, Sumner DS, Strandness Jr DE. An electrically calibrated plethysmograph for direct measurement of limb blood flow. IEEE Trans Biomed Eng 1975; 22: 25-9.
20. G-monomethyl-L-arginine resistant actions of acetylcholine in human forearm vasculature. Clin Sci 1995; 88: 111-17.
21. Buttriss JL, Diplock AT. High-performance liquid chromatography methods for vitamin E in tissues. Methods Enzymol 1984; 105: 131-8.
22. Keaney Jr JF, Gaziano JM, Xu A. Low-dose α-tocopherol improves and high dose α-tocopherol worsens endothelial vasodilator function in cholesterol fed rabbits. J Clin Invest 1994; 93: 844-51.
23. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolaemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546-51.
24. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S. The oxidation of alpha-tocopherol in human low-density lipoprotein by the simultaneous generation of superoxide and nitric oxide. FEBS Lett 1993; 326: 199-203.
25. Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 1992; 85: 1927-38.
26. Liao JK, Shin WS, Lee WY, Clark SL. Oxidised low density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 1995; 270: 319-24.
27. Hirata K, Miki N, Kuroda Y, Sakoda T, Kawashima S, Yokoyama M. Low concentrations of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide mRNA expression in bovine aortic endothelial cells. Circ Res 1995; 76: 958-62.
28. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause or consequence? Lancet 1994; 344: 721-4.
29. Esterbauer H, Puhl H, Dieber-Rotheneder M, Waeg G, Rabl H. Effect of antioxidants on oxidative modification of LDL. Ann Med 1991; 23: 573-81.
30. Jacobs M, Plane F, Bruckdorfer KR. Native and oxidized low-density lipoproteins have different inhibitory effects on endothelium-derived relaxing factor in rabbit aorta. Br J Pharmacol 1990; 100: 21-6.
31. Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolaemic rabbit thoracic aorta. Circulation 1991; 83: 1057-62.
32. Rossitch E, Alexander E, Black PMcL, Cooke JP. L-Arginine normalises endothelial function in cerebral vessels from hypercholesterolaemic rabbits. J Clin Invest 1991; 87: 1295-9.
33. Elliott TG, Barth JD, Mandni GB. Effects of vitamin E on endothelial function in men after myocardial infarction. Am J Cardiol 1995; 76: 1188-90.
34. Gilligan DM, Sack MN, Guetta V, et al. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolaemia. J Am Coll Cardiol 1994; 24: 1611-17.
35. McDowell IF, Brennan GM, McEneny J, et al. The effect of probucol and vitamin E treatment on the oxidation of low-density lipoprotein and forearm vascular response in humans. Eur J Clin Invest 1994; 24: 759-65.
36. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995; 332: 488-93.
37. Lamarche B, Tchernof A, Moorjani S, et al. Small,dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Circulation 1997; 95: 69-75.
38. Gardner CD, Fortmann SP, Krauss RM. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996; 276: 875-81.
39. Goulinet S, Chapman MJ. Plasma LDL and HDL subspecies are heterogeneous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Arterioscler Thromb Vasc Biol 1997; 17: 786-96.
40. Meydani M. Vitamin E. Lancet 1995; 345: 170-5.
41. Mitchell JA, Hecker M, Änggård EE, Vane JR. Cultured endothelial cells maintain their L-arginine level despite the continuous release of EDRF. Eur J Pharmacol 1990; 182: 573-6.
42. Pritchard KA, Groszek L, Smalley DM, et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res 1995; 77: 510-18.
43. Clarkson P, Adams MR, Powe AJ, et al. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolaemic young adults. J Clin Invest 1996; 97: 1989-94.